V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023348 | 20009913 | null | 75 | null | 2017-03-28 | 2017-03-30 | FEC + DOCETAXEL | 02 | null | 20082484 | FEC + DOCETAXEL |
| 20023349 | 20009913 | 1.52 | 58.6 | Neo-adjuvant (N) | 2015-05-05 | 2015-05-31 | FEC + DOCETAXEL | 2 | N | 20082484 | FEC + DOCETAXEL |
| 20023350 | 20009913 | null | null | Adjuvant (A) | 2017-04-03 | 2017-04-23 | FEC + DOCETAXEL | N | N | 20082484 | FEC + DOCETAXEL |
| 20023351 | 20009914 | 1.68 | null | Adjuvant (A) | 2017-02-23 | 2017-02-26 | FEC + DOCETAXEL | N | N | 20082492 | FEC + DOCETAXEL |
| 20023352 | 20009915 | 1.61 | 60.8 | Neo-adjuvant (N) | 2017-04-25 | 2017-05-24 | FEC + DOCETAXEL | 2 | N | 20082494 | FEC + DOCETAXEL |
| 20023353 | 20009915 | 1.62 | null | null | 2014-01-11 | 2014-02-05 | FEC 100 + DOCETAXEL | 2 | N | 20082494 | FEC + DOCETAXEL |
| 20023354 | 20009915 | 1.68 | 64 | Neo-adjuvant (N) | 2014-11-09 | 2014-11-11 | FEC + DOCETAXEL | 2 | N | 20082494 | FEC + DOCETAXEL |
| 20023355 | 20009915 | null | null | Adjuvant (A) | 2017-05-25 | 2017-06-01 | FEC + DOCETAXEL | N | N | 20082494 | FEC + DOCETAXEL |
| 20023356 | 20009915 | 1.62 | 81.4 | Curative (C) | null | 2017-10-12 | FEC + DOCETAXEL | N | null | 20082494 | FEC + DOCETAXEL |
| 20023357 | 20009915 | 1.57 | 51 | Adjuvant (A) | 2015-10-13 | 2015-10-13 | FEC + DOCETAXEL | N | null | 20082494 | FEC + DOCETAXEL |
| 20023358 | 20009916 | 1.69 | 67 | Adjuvant (A) | 2017-05-20 | 2017-06-04 | FEC 100 + DOCETAXEL | 02 | null | 20082516 | FEC + DOCETAXEL |
| 20023359 | 20009917 | 1.62 | 73 | Adjuvant (A) | 2015-04-21 | 2015-04-30 | FEC 100 + DOCETAXEL | N | N | 20082523 | FEC + DOCETAXEL |
| 20023360 | 20009917 | 1.62 | 62.5 | Disease modification (D) | null | 2013-05-24 | FEC + DOCETAXEL | N | N | 20082523 | FEC + DOCETAXEL |
| 20023361 | 20009917 | 1.56 | 61 | Not known (9) | 2014-07-10 | 2014-08-07 | FEC 100 + DOCETAXEL | N | N | 20082523 | FEC + DOCETAXEL |
| 20023362 | 20009917 | 1.6 | 94.6 | Neo-adjuvant (N) | 2013-05-31 | 2013-06-05 | FEC + DOCETAXEL | 02 | Y | 20082523 | FEC + DOCETAXEL |
| 20023363 | 20009917 | 1.69 | 66.85 | Adjuvant (A) | 2016-08-23 | 2016-08-24 | FEC + DOCETAXEL | 02 | N | 20082523 | FEC + DOCETAXEL |
| 20023364 | 20009917 | 1.66 | 51.95 | Disease modification (D) | 2013-09-29 | 2013-10-18 | FEC + DOCETAXEL | 02 | N | 20082523 | FEC + DOCETAXEL |
| 20023365 | 20145839 | 1.6 | 53.2 | null | 2016-09-01 | 2016-10-06 | FEC + DOCETAXEL | null | null | 20082546 | FEC + DOCETAXEL |
| 20023366 | 20145839 | 1.68 | 76.6 | Adjuvant (A) | 2016-01-07 | 2016-01-07 | FEC + DOCETAXEL | 2 | N | 20082546 | FEC + DOCETAXEL |
| 20023367 | 20009918 | 1.6 | 60.6 | Neo-adjuvant (N) | 2013-07-19 | 2013-07-22 | FEC + DOCETAXEL | 02 | N | 20082553 | FEC + DOCETAXEL |
| 20023368 | 20009919 | 1.64 | 68 | Adjuvant (A) | 2015-07-01 | 2015-07-01 | FEC + DOCETAXEL | 02 | N | 20082554 | FEC + DOCETAXEL |
| 20023369 | 20009919 | 1.53 | 108 | Adjuvant (A) | 2017-08-22 | 2017-08-25 | FEC + DOCETAXEL | 02 | N | 20082554 | FEC + DOCETAXEL |
| 20023370 | 20009919 | 1.62 | 56.5 | null | null | 2016-07-26 | FEC + DOCETAXEL | N | N | 20082554 | FEC + DOCETAXEL |
| 20023371 | 20009920 | 1.59 | 92 | Curative (C) | 2015-05-19 | 2015-05-23 | FEC 100 + DOCETAXEL | 02 | N | 20082559 | FEC + DOCETAXEL |
| 20023372 | 20009921 | 1.75 | 104.4 | Neo-adjuvant (N) | 2017-12-01 | 2017-12-07 | FEC + DOCETAXEL | 2 | N | 20082560 | FEC + DOCETAXEL |
| 20023373 | 20009921 | null | 68.2 | Neo-adjuvant (N) | 2017-01-19 | 2017-02-03 | FEC + DOCETAXEL | N | N | 20082560 | FEC + DOCETAXEL |
| 20023374 | 20009921 | 1.58 | 73.3 | Adjuvant (A) | 2015-11-09 | 2015-11-10 | FEC + DOCETAXEL | 02 | null | 20082560 | FEC + DOCETAXEL |
| 20023375 | 20009922 | 1.62 | null | Curative (C) | null | 2016-08-21 | FEC + DOCETAXEL | N | N | 20082569 | FEC + DOCETAXEL |
| 20023376 | 20009922 | null | 67.8 | Adjuvant (A) | null | 2013-09-24 | FEC + DOCETAXEL | N | N | 20082569 | FEC + DOCETAXEL |
| 20023377 | 20009923 | 1.63 | 54 | Adjuvant (A) | 2014-03-19 | 2014-03-19 | FEC + DOCETAXEL | 02 | N | 20082576 | FEC + DOCETAXEL |
| 20023378 | 20009923 | 1.64 | 72.7 | Not known (9) | 2015-03-06 | 2015-03-20 | FEC 100 + DOCETAXEL | N | N | 20082576 | FEC + DOCETAXEL |
| 20023379 | 20009924 | 1.69 | 69 | Adjuvant (A) | 2017-12-06 | 2017-12-15 | FEC + DOCETAXEL | N | N | 20082590 | FEC + DOCETAXEL |
| 20023380 | 20009924 | 1.73 | 173 | Neo-adjuvant (N) | 2015-03-06 | 2015-04-05 | FEC 100 + DOCETAXEL | 2 | N | 20082590 | FEC + DOCETAXEL |
| 20023381 | 20009924 | 1.72 | 67.1 | Adjuvant (A) | null | 2013-08-10 | FEC + DOCETAXEL | N | N | 20082590 | FEC + DOCETAXEL |
| 20023382 | 20009924 | 1.65 | 100 | Not known (9) | 2018-03-22 | 2018-03-23 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20082590 | FEC + DOCETAXEL |
| 20023383 | 20009925 | 1.62 | 65.3 | Adjuvant (A) | 2015-11-12 | 2015-11-13 | FEC 100 + DOCETAXEL | 2 | N | 20082622 | FEC + DOCETAXEL |
| 20023384 | 20070697 | 1.55 | 91.8 | Adjuvant (A) | 2015-05-15 | 2015-05-16 | FEC + DOCETAXEL | 2 | null | 20082626 | FEC + DOCETAXEL |
| 20023385 | 20009926 | 1.53 | 69.6 | Neo-adjuvant (N) | 2017-10-07 | 2017-10-11 | FEC 100 + DOCETAXEL | 2 | N | 20082629 | FEC + DOCETAXEL |
| 20023386 | 20070698 | null | 77.8 | Adjuvant (A) | 2014-05-16 | 2014-05-31 | FEC + DOCETAXEL | N | N | 20082631 | FEC + DOCETAXEL |
| 20023387 | 20009927 | null | 89.8 | Neo-adjuvant (N) | 2017-06-08 | 2017-06-16 | FEC 60 OR 75 + DOCETAXEL | N | N | 20082634 | FEC + DOCETAXEL |
| 20023388 | 20009927 | null | null | Adjuvant (A) | 2014-05-02 | 2014-05-02 | FEC + DOCETAXEL | N | N | 20082634 | FEC + DOCETAXEL |
| 20023389 | 20009928 | null | 90 | Adjuvant (A) | 2016-01-31 | 2016-02-19 | FEC + DOCETAXEL | N | N | 20082639 | FEC + DOCETAXEL |
| 20023390 | 20009928 | 1.71 | 56 | Curative (C) | 2018-01-23 | 2018-01-23 | FEC 100 + DOCETAXEL | 02 | N | 20082639 | FEC + DOCETAXEL |
| 20023391 | 20009928 | 1.56 | null | Adjuvant (A) | 2014-05-21 | 2014-06-04 | FEC + DOCETAXEL | N | N | 20082639 | FEC + DOCETAXEL |
| 20023392 | 20009929 | 1.63 | 52 | Adjuvant (A) | null | 2017-05-07 | FEC 100 + DOCETAXEL | N | Y | 20082648 | FEC + DOCETAXEL |
| 20023393 | 20009930 | 1.62 | 79.4 | Adjuvant (A) | 2014-02-05 | 2014-02-15 | FEC 100 + DOCETAXEL | N | N | 20082662 | FEC + DOCETAXEL |
| 20023394 | 20009931 | 1.55 | 60 | Neo-adjuvant (N) | 2014-03-11 | 2014-03-12 | FEC + DOCETAXEL | N | N | 20082687 | FEC + DOCETAXEL |
| 20023395 | 20009932 | 1.59 | 69 | Adjuvant (A) | 2014-11-27 | 2014-11-28 | FEC + DOCETAXEL | 02 | N | 20082700 | FEC + DOCETAXEL |
| 20023396 | 20009932 | 1.62 | 67 | Adjuvant (A) | 2017-06-12 | 2017-06-12 | FEC + DOCETAXEL | N | N | 20082700 | FEC + DOCETAXEL |
| 20023397 | 20009932 | 1.71 | 69.7 | null | 2016-07-27 | 2016-08-19 | FEC + DOCETAXEL | N | null | 20082700 | FEC + DOCETAXEL |